J
Jack
"ReValving--that is, percutaneously implanting a new heart valve over a defective valve instead of cutting it out--redefines the way valve replacement is performed, changing it from a very complex surgical procedure to a relatively simple, less invasive one. In short, ReValving is the next-generation cath lab therapy for interventional cardiology."
"We believe that CoreValve has redefined the way heart valve replacement will be performed in the future. The ability to resolve a patient's aortic stenosis by performing the CoreValve ReValving procedure in a cath lab is truly a revolutionary event for interventional cardiology. Indeed, we believe this ranks in importance alongside the first angioplasty performed in a human 27 years ago by Dr. Andreas Gruentzig," said Dr. Jacques Seguin, chairman, CEO and founder of CoreValve.
-- Jacques Seguin, MD, PhD, Chairman, CEO and Co-Founder, CoreValve, S.A.
http://home.businesswire.com/portal...d=news_view&newsId=20040720005586&newsLang=en
"We believe that CoreValve has redefined the way heart valve replacement will be performed in the future. The ability to resolve a patient's aortic stenosis by performing the CoreValve ReValving procedure in a cath lab is truly a revolutionary event for interventional cardiology. Indeed, we believe this ranks in importance alongside the first angioplasty performed in a human 27 years ago by Dr. Andreas Gruentzig," said Dr. Jacques Seguin, chairman, CEO and founder of CoreValve.
-- Jacques Seguin, MD, PhD, Chairman, CEO and Co-Founder, CoreValve, S.A.
http://home.businesswire.com/portal...d=news_view&newsId=20040720005586&newsLang=en